{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T16:54:30Z","timestamp":1722963270762},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/s11095-004-1190-6","type":"journal-article","created":{"date-parts":[[2005,3,16]],"date-time":"2005-03-16T10:57:26Z","timestamp":1110970646000},"page":"228-234","source":"Crossref","is-referenced-by-count":15,"title":["Altered Pharmacokinetics of Paclitaxel in Experimental Hepatic or Renal Failure"],"prefix":"10.1007","volume":"22","author":[{"given":"Mari","family":"Jiko","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikuko","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Okuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Inui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","volume":"332","author":"E. K. Rowinsky","year":"1995","unstructured":"1. E. K. Rowinsky and R. C. Donehower. Paclitaxel (Taxol). N. Engl. J. Med. 332:1004?1014 (1995).","journal-title":"N. Engl. J. Med."},{"key":"CR2","first-page":"566","volume":"275","author":"D. S. Sonnichsen","year":"1995","unstructured":"2. D. S. Sonnichsen, Q. Liu, E. G. Schuetz, J. D. Schuetz, A. Pappo, and M. V. Relling. Variability in human cytochrome P450 paclitaxel metabolism. J. Pharmcol. Exp. Ther. 275:566?575 (1995).","journal-title":"J. Pharmcol. Exp. Ther."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2165\/00003088-199427040-00002","volume":"27","author":"D. S. Sonnichsen","year":"1994","unstructured":"3. D. S. Sonnichsen and M. V. Relling. Clinical pharmacokinetics of paclitaxel. Clin. Pharmacokinet. 27:256?269 (1994).","journal-title":"Clin. Pharmacokinet."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/JCO.1995.13.1.180","volume":"13","author":"L. Gianni","year":"1995","unstructured":"4. L. Gianni, C. M. Kearns, A. Giani, G. Capri, L. Vigan\u00f3, A.Locatelli, G. Bonadonna, and M. J. Egorin. Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic\/ pharmacodynamic relationships in humans. J. Clin. Oncol. 13: 180?190 (1995).","journal-title":"J. Clin. Oncol."},{"key":"CR5","first-page":"599","volume":"1","author":"T. Ohtsu","year":"1995","unstructured":"5. T. Ohtsu, Y. Sasaki, T. Tamura, Y. Miyata, H. Nakanomyo, Y. Nishiwaki, and N. Saijo. Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3-hour infusion versus a 24-hour infusion. Clin. Cancer Res. 1:599?606 (1995).","journal-title":"Clin. Cancer Res."},{"key":"CR6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1200\/JCO.1997.15.1.317","volume":"15","author":"M. T. Huizing","year":"1997","unstructured":"6. M. T. Huizing, G. Giaccone, L. J. C. van Warmerdam, H. Rosing, P. J. M. Bakker, J. B. Vermorken, P. E. Postmus, N. van Zandwijk, M. G. J. Koolen, W. W. ten Bokkel-Huinink, W. J. F. van der Vijg, F. J. Bierhorst, A. Lai, O. Dalesio, H. M. Pinedo, C. H. N. Veenhof, and J. H. Beijnen. Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. J. Clin. Oncol. 15:317? 329 (1997).","journal-title":"J. Clin. Oncol."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2165\/00003088-199937050-00004","volume":"37","author":"V. Rodighiero","year":"1999","unstructured":"7. V. Rodighiero. Effects of liver disease on pharmacokinetics. An update. Clin. Pharmacokinet. 37:399?431 (1999).","journal-title":"Clin. Pharmacokinet."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1139\/y00-066","volume":"78","author":"M.-C. Bastien","year":"2000","unstructured":"8. M.-C. Bastien, F. Leblond, V. Pichette, and J.-P. Villeneuve. Differential alteration of cytochrome P450 isozymes in two experimental models of cirrhosis. Can. J. Physiol. Pharmacol. 78:912? 919 (2000).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"CR9","first-page":"34","volume":"24","author":"V. R. N. Panday","year":"1997","unstructured":"9. V. R. N. Panday, M. T. Huizing, P. H. B. Willemse, A. De-Graeff, W. W. ten Bokkel-Huinink, J. B. Vermorken, and J. H. Beijnen. Hepatic metabolism of paclitaxel and its impact in patients with altered hepatic function. Semin. Oncol. 24:34?38 (1997).","journal-title":"Semin. Oncol."},{"key":"CR10","first-page":"1077","volume":"9","author":"R. Bruno","year":"2003","unstructured":"10. R. Bruno, R. Olivares, J. Berille, P. Chaikin, N. Vivier, L. Hammershaimb, G. R. Rhodes, and J. R. Rigas. ?-1-Acid glycoprotein as an independent predictor for treatment effects and a prognostic factor of survival in patients with non-small cell lung cancer treated with docetaxel. Clin. Cancer Res. 9:1077?1082 (2003).","journal-title":"Clin. Cancer Res."},{"key":"CR11","series-title":"Applied Therapeutics","first-page":"83","volume-title":"Applied Pharmacokinetics","author":"T. P. Gibson","year":"1986","unstructured":"11. T. P. Gibson. Influence of renal disease on pharmacokinetics. In W. E. Evans, L. J. Schentag, and W. J. Jusko (eds.), Applied Pharmacokinetics, 2nd ed, Applied Therapeutics, Washington, DC, 1986, pp. 83?115","edition":"2"},{"key":"CR12","first-page":"1317","volume":"28","author":"F. A. Leblond","year":"2000","unstructured":"12. F. A. Leblond, L. Giroux, J.-P. Villeneuve, and V. Pichette. Decreased in vivo metabolism of drugs in chronic renal failure. Drug Metab. Dispos. 28:1317?1320 (2000).","journal-title":"Drug Metab. Dispos."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0009-9236(03)00056-0","volume":"73","author":"T. C. Dowling","year":"2003","unstructured":"13. T. C. Dowling, A. E. Briglia, J. C. Fink, D. S. Hanes, P. D. Light, L. Stackiewicz, C. S. Karyekar, N. D. Eddington, M. R. Weir, and W. L. Henrich. Characterization of hepatic cytochrome P4503A activity in patients with end-stage renal disease. Clin. Pharmacol. Ther. 73:427?434 (2003).","journal-title":"Clin. Pharmacol. Ther."},{"key":"CR14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1023\/A:1007508325512","volume":"17","author":"S.-S. Hong","year":"2000","unstructured":"14. S.-S. Hong, S.-J. Chung, and C.-K. Shim. Functional impairment of sinusoidal membrane transport of organic cations in rats with CCl4-induced hepatic failure. Pharm. Res. 17:833?838 (2000).","journal-title":"Pharm. Res."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1046\/j.1523-1755.2002.00464.x","volume":"62","author":"L. Ji","year":"2002","unstructured":"15. L. Ji, S. Masuda, H. Saito, and K. Inui. Down-regulation of rat organic cation transporter rOCT2 by 5\/6 nephrectomy. Kidney Int. 62:514?524 (2002).","journal-title":"Kidney Int."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/0024-3205(74)90118-0","volume":"15","author":"M. Sugiura","year":"1974","unstructured":"16. M. Sugiura, K. Iwasaki, H. Noguchi, and R. Kato. Evidence for the involvement of cytochrome P-450 in tiaramide N-oxide reduction. Life Sci. 15:1433?1442 (1974).","journal-title":"Life Sci."},{"key":"CR17","first-page":"502","volume":"25","author":"R. W. Wang","year":"1997","unstructured":"17. R. W. Wang, D. J. Newton, T. D. Scheri, and A. Y. H. Lu. Human cytochrome P450 3A4-catalyzed testosterone 6?-hydroxylation and erythromycin N-demethylation. Drug Metab. Dispos. 25:502? 507 (1997).","journal-title":"Drug Metab. Dispos."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/jhep.2003.50094","volume":"37","author":"T. Iwahori","year":"2003","unstructured":"18. T. Iwahori, T. Matsuura, H. Maehashi, K. Sugo, M. Saito, M. Hosokawa, K. Chiba, T. Masaki, H. Aizaki, K. Ohkawa, and T. Suzuki. CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver. Hepatology 37:665? 673 (2003).","journal-title":"Hepatology"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0378-4347(93)80100-I","volume":"621","author":"T. A. Willey","year":"1993","unstructured":"19. T. A. Willey, E. J. Bekos, R. C. Gaver, G. F. Duncan, L. K. Tay, J. H. Beijnen, and R. H. Farmen. High-performance liquid chromatographic procedure for the quantitative determination of paclitaxel (Taxol\u00ae) in human plasma. J. Chromatogr. 621:231?238 (1993).","journal-title":"J. Chromatogr."},{"key":"CR20","first-page":"937","volume":"25","author":"J.-S. Choi","year":"2002","unstructured":"20. J.-S. Choi. Pharmacokinetics of paclitaxel in rabbits with carbon tetrachloride-induced hepatic failure. Arch. Pharm. Res. 25:937? 977 (2002).","journal-title":"Arch. Pharm. Res."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1211\/0022357021771931","volume":"54","author":"H. Okabe","year":"2002","unstructured":"21. H. Okabe, I. Yano, Y. Hashimoto, H. Saito, and K. Inui. Evaluation of increased bioavailability of tacrolimus in rats with experimental renal dysfunction. J. Pharm. Pharmacol. 54:65?70 (2002).","journal-title":"J. Pharm. Pharmacol."},{"key":"CR22","first-page":"1286","volume":"23","author":"C. D. Anderson","year":"1995","unstructured":"22. C. D. Anderson, J. Wang, G. N. Kumar, J. M. Mcmillan, U. K. Walle, and T. Walle. Dexamethasone induction of taxol metabolism in the rat. Drug Metab. Dispos. 23:1286?1290 (1995).","journal-title":"Drug Metab. Dispos."},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1023\/A:1026131216669","volume":"20","author":"H. Okabe","year":"2003","unstructured":"23. H. Okabe, M. Hasunuma, and Y. Hashimoto. The hepatic and intestinal metabolic activities of P450 in rats with surgery- and drug-induced renal dysfunction. Pharm. Res. 20:1591?1594 (2003).","journal-title":"Pharm. Res."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1073\/pnas.94.5.2031","volume":"94","author":"A. Sparreboom","year":"1997","unstructured":"24. A. Sparreboom, J. van Asperen, U. Mayer, A. H. Schinkel, J. W. Smit, D. K. F. Meijer, P. Borst, W. J. Nooijen, J. H. Beijnen, and O. van Tellingen. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc. Natl. Acad. Sci. USA 94:2031?2035 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"CR25","first-page":"982","volume":"26","author":"M. R. Feng","year":"1998","unstructured":"25. M. R. Feng, J. Loo, and J. Wright. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Drug Metab. Dispos. 26:982?988 (1998).","journal-title":"Drug Metab. Dispos."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1201\/b14095","volume-title":"Pharmacokinetics","author":"M. Gibaldi","year":"1982","unstructured":"26. M. Gibaldi and D. Perrier. Clearance concepts. In M. Gibaldi and D. Perrier (eds.), Pharmacokinetics, Marcel Dekker, New York, 1982, pp. 319?353."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ki.1988.99","volume":"33","author":"R. Vanholder","year":"1988","unstructured":"27. R. Vanholder, N. van Landschoot, R. De-Smet, A. Schoots, and S. Ringoir. Drug protein binding in chronic renal failure: evaluation of nine drugs. Kidney Int. 33:996?1004 (1988).","journal-title":"Kidney Int."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1172\/JCI108035","volume":"55","author":"R. Gugler","year":"1975","unstructured":"28. R. Gugler, D. W. Shoeman, D. H. Huffman, J. B. Cohlmia, and D. L. Azarnoff. Pharmacokinetics of drugs in patients with the nephrotic syndrome. J. Clin. Invest. 55:1182?1189 (1975).","journal-title":"J. Clin. Invest."},{"key":"CR29","first-page":"337","volume":"80","author":"G. N. Kumar","year":"1993","unstructured":"29. G. N. Kumar, U. K. Walle, K. N. Bhalla, and T. Walle. Binding of taxol to human plasma, albumin and ?1-acid glycoprotein. Res. Commun. Chem. Pathol. Pharmacol. 80:337?344 (1993).","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ab.2003.07.024","volume":"324","author":"H. J. G. D. Bongard van den","year":"2004","unstructured":"30. H. J. G. D. van den Bongard, E. M. Kemper, O. van Tellingen, H. Rosing, R. A. A. Math\u00f4t, J. H. M. Schellens, and J. H. Beijnen. Development and validation of a method to determine the unbound paclitaxel fraction in human plasma. Anal. Biochem. 324: 11?15 (2004).","journal-title":"Anal. Biochem."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-004-1190-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-004-1190-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-004-1190-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T23:25:03Z","timestamp":1625613903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-004-1190-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["1190"],"URL":"https:\/\/doi.org\/10.1007\/s11095-004-1190-6","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}